home / stock / ecl / ecl articles

ECL Articles, Ecolab Inc. - From 05/21/24

Stock Information
Company Name: Ecolab Inc.
Stock Symbol: ECL
Market: NYSE
Website: ecolab.com
Menu
ECL ECL Quote ECL Short ECL News ECL Articles ECL Message Board
Get ECL Alerts

News, Short Squeeze, Breakout and More Instantly...
$1000 Invested In This Stock 20 Years Ago Would Be Worth $7,600 Today | Benzinga

Ecolab (NYSE:ECL) has outperformed the market over the past 20 years by 2.71% on an annualized basis producing an average annual return of 10.75%. ...
Jim Cramer Says This Materials Stock Is A 'Great Spec,' Plus He Recommends Buying Abercrombie & Fitch | Benzinga

On CNBC's “Mad Money Lightning Round,” Jim Cramer recommends buying Abercrombie & Fitch Co. (NYSE:ANF). Abercrombie & Fitc...

HealthEquity Closes Conduent's BenefitWallet Acquisition | Benzinga

HealthEquity (NASDAQ: HQY) recently announced the completion of the acquisition of Conduent's BenefitWallet Health Savings Account portfolio. I...

Here's Why You Should Hold Onto Dow Stock for Now | Benzinga

Dow Inc. (NYSE: DOW) is expected to gain from cost and productivity actions and investment in high-return projects. However, it faces headwinds fro...
Philips' Gets FDA Recall for Trilogy Ventilator Glitch | Benzinga

Koninklijke Philips (NYSE: PHG) notified its customers about a possible power malfunction in its Trilogy Evo continuous ventilators and initiated a...

FMC Corp Teams Up With AgroSpheres for Bioinsecticides | Benzinga

FMC Corporation (NYSE: FMC) recently entered into a research partnership with AgroSpheres, a biotechnology firm dedicated to sustainable crop prote...

Jim Cramer Says Buy This Tech Stock Right Here, Likes Cognex | Benzinga

On CNBC's “Mad Money Lightning Round,” Jim Cramer recommended buying Cloudflare, Inc. (NYSE:NET) “right here.” The com...
Ecolab Gains After Beating Q1 Sales Expectations And Raising FY24 Outlook; Divests Surgical Segment For $950M | Benzinga

Ecolab Inc. (NYSE:ECL) shares are gaining on Tuesday after the company reported first-quarter results. The company reported quarterly adj...

West Pharmaceutical Q1 Earnings Beat, HVP Sales Weak | Benzinga

West Pharmaceutical Services, Inc. (NYSE: WST) reported first-quarter 2024 adjusted earnings per share (ETF:EPS) of $1.56, which beat the Zacks Con...

$100 Invested In This Stock 20 Years Ago Would Be Worth $800 Today | Benzinga

Ecolab (NYSE:ECL) has outperformed the market over the past 20 years by 2.82% on an annualized basis producing an average annual return of 10.47%. ...
Previous 10 Next 10